TGFB1 and neoplasm: We expected that inhibition of ERK signaling pathway would reduce tumor growth in DNM2 mice, and based on this, we plan to explore a combined strategy (i.e., ERK + TGF-β inhibitors) for treating mCRPC in animal models.